Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioning. - Jubas S; Collins K; Obara K; Liu HH; Kemper RM; Kelley ALW; Goel A; Dunlap TC; Zhu J; Randolph RM; Ptachcinski JR; Bizzell ME; et al. (Transplantation and cellular therapy, 2026)